Infection Innovative Medicines

United States

Infection Innovative Medicines

United States
SEARCH FILTERS
Time filter
Source Type

Murphy-Benenato K.E.,Infection Innovative Medicines | Murphy-Benenato K.E.,Moderna Therapeutics | Bhagunde P.R.,Infection Innovative Medicines | Bhagunde P.R.,Merck And Co. | And 30 more authors.
Journal of Medicinal Chemistry | Year: 2015

To identify new agents for the treatment of multi-drug-resistant Pseudomonas aeruginosa, we focused on siderophore-conjugated monocarbams. This class of monocyclic β-lactams are stable to metallo-β-lactamases and have excellent P. aeruginosa activities due to their ability to exploit the iron uptake machinery of Gram-negative bacteria. Our medicinal chemistry plan focused on identifying a molecule with optimal potency and physical properties and activity for in vivo efficacy. Modifications to the monocarbam linker, siderophore, and oxime portion of the molecules were examined. Through these efforts, a series of pyrrolidinone-based monocarbams with good P. aeruginosa cellular activity (P. aeruginosa MIC90 = 2 μg/mL), free fraction levels (>20% free), and hydrolytic stability (t1/2 ≥ 100 h) were identified. To differentiate the lead compounds and enable prioritization for in vivo studies, we applied a semi-mechanistic pharmacokinetic/pharmacodynamic model to enable prediction of in vivo efficacy from in vitro data. © 2015 American Chemical Society.


Murphy-Benenato K.E.,Infection Innovative Medicines | Olivier N.,Astrazeneca | Choy A.,Infection Innovative Medicines | Ross P.L.,Astrazeneca | And 4 more authors.
ACS Medicinal Chemistry Letters | Year: 2014

In the search for novel Gram-negative agents, we performed a comprehensive search of the AstraZeneca collection and identified a tetrahydropyran-based matrix metalloprotease (MMP) inhibitor that demonstrated nanomolar inhibition of UDP-3-O-(acyl)-N-acetylglucosamine deacetylase (LpxC). Crystallographic studies in Aquifex aeolicus LpxC indicated the tetrahydropyran engaged in the same hydrogen bonds and van der Waals interactions as other known inhibitors. Systematic optimization of three locales on the scaffold provided compounds with improved Gram-negative activity. However, the optimization of LpxC activity was not accompanied by reduced inhibition of MMPs. Comparison of the crystal structure of the native product, UDP-3-O-(acyl)-glucosamine, in Aquifex aeolicus to the structure of a tetrahydropyran-based inhibitor indicates pathways for future optimization. © 2014 American Chemical Society.

Loading Infection Innovative Medicines collaborators
Loading Infection Innovative Medicines collaborators